Rheumatology.net

Rheumatology Xagena

Xagena Mappa
Medical Meeting
Mediexplorer.it
Cardiobase

Search results for "Orencia"

Orencia ( Abatacept ) SC ( subcutaneous ) and IV ( intravenous ) is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and im ...


The aim of a study was to assess long-term tolerability, safety, and efficacy of subcutaneous ( SC ) Abatacept ( Orencia ) in Methotrexate-refractory patients with rheumatoid arthritis. The phase I ...


The results of several new sub-analyses of the phase IIIb AVERT ( Assessing Very Early Rheumatoid arthritis Treatment ) trial that investigated the use of Abatacept ( Orencia ) plus Methotrexate ( MTX ...


A study aimed to assess the relative efficacy and safety of biologics and Tofacitinib ( Xeljanz ) in patients with rheumatoid arthritis showing an inadequate response to tumor necrosis factor ( TNF ) ...